Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483–94.
Article PubMed CAS Google Scholar
Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66:8–16.
Article PubMed CAS Google Scholar
Kim JE, Kim HJ, Lew BL, Lee KH, Hong SP, Jang YH, et al. Consensus guidelines for the treatment of atopic dermatitis in Korea (part I): general management and topical treatment. Ann Dermatol. 2015;27:563–77.
Article PubMed PubMed Central CAS Google Scholar
Cotter DG, Schairer D, Eichenfield L. Emerging therapies for atopic dermatitis: JAK inhibitors. J Am Acad Dermatol. 2018;78:S53–62.
Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, et al. Guidelines for management of atopic dermatitis. J Dermatol. 2009;36:563–77.
Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34:747–54.
Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation. 2003;107:929–34.
Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24:98–103.
Article PubMed PubMed Central Google Scholar
Ratajczak M, Kucia M, Jadczyk T, Greco N, Wojakowski W, Tendera M, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia. 2012;26:1166–73.
Article PubMed CAS Google Scholar
Marks PW, Witten CM, Califf RM. Clarifying stem-cell therapy’s benefits and risks. N Engl J Med. 2017;376:1007–9.
Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49:e346–446.
Article PubMed PubMed Central Google Scholar
Boriachek K, Islam MN, Möller A, Salomon C, Nguyen NT, Hossain MSA, et al. Biological functions and current advances in isolation and detection strategies for exosome nanovesicles. Small. 2018;14:1702153.
Toh WS, Lai RC, Zhang B, Lim SK. MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans. 2018;46:843–53.
Article PubMed PubMed Central CAS Google Scholar
Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487–514.
Article PubMed CAS Google Scholar
Hu Q, Su H, Li J, Lyon C, Tang W, Wan M, et al. Clinical applications of exosome membrane proteins. Precis Clin Med. 2020;3:54–66.
Article PubMed PubMed Central Google Scholar
Aheget H, Tristán-Manzano M, Mazini L, Cortijo-Gutierrez M, Galindo-Moreno P, Herrera C, et al. Exosome: a new player in translational nanomedicine. J Clin Med. 2020;9:2380.
Article PubMed PubMed Central CAS Google Scholar
Kim HY, Bhang SH. Stem cell-engineered nanovesicles exert proangiogenic and neuroprotective effects. Materials. 2021;14:1078.
Article PubMed PubMed Central CAS Google Scholar
Jo W, Kim J, Yoon J, Jeong D, Cho S, Jeong H, et al. Large-scale generation of cell-derived nanovesicles. Nanoscale. 2014;6:12056–64.
Article PubMed CAS Google Scholar
Yu Y, Jin H, Li L, Zhang X, Zheng C, Gao X, et al. An injectable, activated neutrophil-derived exosome mimetics/extracellular matrix hybrid hydrogel with antibacterial activity and wound healing promotion effect for diabetic wound therapy. J Nanobiotechnol. 2023;21:308.
Fujii M. Current understanding of pathophysiological mechanisms of atopic dermatitis: interactions among skin barrier dysfunction, immune abnormalities and pruritus. Biol Pharm Bull. 2020;43:12–9.
Article PubMed CAS Google Scholar
Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. Int Sch Res Not. 2014;2014:354250.
Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep. 2008;8:306–11.
Article PubMed CAS Google Scholar
Grobe W, Bieber T, Novak N. Pathophysiology of atopic dermatitis. JDDG J der Deutsch Dermatol Gesellschaft. 2019;17:433–40.
Luo J, Zhu Z, Zhai Y, Zeng J, Li L, Wang D, et al. The role of TSLP in atopic dermatitis: from pathogenetic molecule to therapeutical target. Med Inflamm. 2023;2023:7697699.
Liu YJ. TSLP in epithelial cell and dendritic cell cross talk. Adv Immunol. 2009;101:1–25.
Article PubMed PubMed Central CAS Google Scholar
Progneaux A, Evrard C, De Glas V, Fontaine A, Dotreppe C, De Vuyst E, et al. Keratinocytes activated by IL-4/IL-13 express IL-2Rγ with consequences on epidermal barrier function. Exp Dermatol. 2023;32:660–70.
Article PubMed CAS Google Scholar
Tazawa T, Sugiura H, Sugiura Y, Uehara M. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch Dermatol Res. 2004;295:459–64.
Article PubMed CAS Google Scholar
Furue M, Yamamura K, Kido-Nakahara M, Nakahara T, Fukui Y. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis. Allergy. 2018;73:29–36.
Article PubMed CAS Google Scholar
Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G, et al. The pruritus-and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol. 2016;138:500–8.
Article PubMed CAS Google Scholar
Zhang DJ, Hao F, Qian T, Cheng HX. Expression of helper and regulatory T cells in atopic dermatitis:a meta-analysis. Front Pediatr. 2022:10:777992.
Eirefelt S, Stahlhut M, Svitacheva N, Carnerup MA, Da Rosa JMC, Ewald DA, et al. Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment. Sci Rep. 2022;12:1501.
Article PubMed PubMed Central CAS Google Scholar
Ahluwalia A. Topical glucocorticoids and the skin-mechanisms of action: an update. Mediators Inflamm. 1998;7:183–93.
Article PubMed PubMed Central CAS Google Scholar
Uva L, Miguel D, Pinheiro C, Antunes J, Cruz D, Ferreira J, et al. Mechanisms of action of topical corticosteroids in psoriasis. Int J Endocrinol. 2012;2012:561018.
Article PubMed PubMed Central Google Scholar
Guichard A, Humbert P, Tissot M, Muret P, Courderot-Masuyer C, Viennet C. Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT. Int J Pharm. 2015;479:422–9.
Park H-S, Lee SC, Cardenas ME, Heitman J. Calcium-calmodulin-calcineurin signaling: a globally conserved virulence cascade in eukaryotic microbial pathogens. Cell Host Microbe. 2019;26:453–62.
Article PubMed PubMed Central CAS Google Scholar
Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, et al. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol. 2004;151:3–27.
留言 (0)